Buscar
iSpecimen Inc
ISPCAñadir a la lista de seguimiento
1.880USD
+0.050+2.73%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
34.85KCap. mercado
PérdidaP/E TTM
Más Datos de iSpecimen Inc Compañía
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Información de iSpecimen Inc
Símbolo de cotizaciónISPC
Nombre de la empresaiSpecimen Inc
Fecha de salida a bolsaJun 17, 2021
Director ejecutivoField (Katharyn)
Número de empleados24
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 17
Dirección8 Cabot Road
CiudadWOBURN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08101
Teléfono17813016700
Sitio Webhttps://www.ispecimen.com/
Símbolo de cotizaciónISPC
Fecha de salida a bolsaJun 17, 2021
Director ejecutivoField (Katharyn)
Ejecutivos de iSpecimen Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de iSpecimen Inc?
Los cinco principales accionistas de iSpecimen Inc son: Mr. Avtar Dhaliwal
¿Cuántas instituciones poseen acciones de iSpecimen Inc (ISPC)?
A fecha de 2026Q1, 31 instituciones poseen acciones de iSpecimen Inc, con un valor de mercado combinado de aproximadamente 5.11K, lo que representa el 0.39% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -79730.00.
¿Cuál es la mayor fuente de ganancias de iSpecimen Inc?
El 2026Q1, el segmento empresarial Specimens – contracts with customers generó la ganancia más alta para iSpecimen Inc, ascendiendo a 95.82K y representando el 89.89% de la ganancia total.